EX-99.2 3 ats-financialstatementsxfy.htm EX-99.2 Document

Appendix 99.2


















image2a.jpg



ATS CORPORATION

Interim Condensed Consolidated Financial Statements

For the period ended December 31, 2023

(Unaudited)















ATS CORPORATION
Interim Condensed Consolidated Statements of Financial Position
(in thousands of Canadian dollars - unaudited)
As atNoteDecember 31
2023
March 31
2023
ASSETS
13
Current assets
Cash and cash equivalents
 
$260,888 $159,867 
Accounts receivable
19
557,402 399,741 
Income tax receivable
 
15,363 15,160 
Contract assets
19
589,693 526,990 
Inventories
5
312,762 256,866 
Deposits, prepaids and other assets
6
113,187 93,350 
 
1,849,295 1,451,974 
Non-current assets
Property, plant and equipment
 
284,456 263,119 
Right-of-use assets
7
106,378 94,212 
Other assets
8
11,339 16,679 
Goodwill
9
1,237,884 1,118,262 
Intangible assets
10
682,316 593,210 
Deferred income tax assets156,356 6,337 
 
2,328,729 2,091,819 
Total assets
 
$4,178,024 $3,543,793 
LIABILITIES AND EQUITY
Current liabilities
Bank indebtedness
13
$5,179 $5,824 
Accounts payable and accrued liabilities
 
617,897 647,629 
Income tax payable
 
47,268 38,904 
Contract liabilities
19
356,311 296,555 
Provisions
12
36,623 30,600 
Current portion of lease liabilities
7
26,661 23,994 
Current portion of long-term debt
13
207 65 
 
1,090,146 1,043,571 
Non-current liabilities
Employee benefits
24,014 25,486 
Long-term lease liabilities
7
85,263 73,255 
Long-term debt
13
1,219,605 1,155,721 
Deferred income tax liabilities
15
124,031 104,459 
Other long-term liabilities
8
16,699 10,718 
 
1,469,612 1,369,639 
Total liabilities
 
$2,559,758 $2,413,210 
Commitments and contingencies
13, 17
EQUITY
Share capital
14
$865,649 $520,633 
Contributed surplus
 
23,064 15,468 
Accumulated other comprehensive income
 
49,889 60,040 
Retained earnings
 
676,454 530,707 
Equity attributable to shareholders
 
1,615,056 1,126,848 
Non-controlling interests
 
3,210 3,735 
Total equity
 
1,618,266 1,130,583 
Total liabilities and equity
 
$4,178,024 $3,543,793 

See accompanying notes to the interim condensed consolidated financial statements.











1

ATS CORPORATION
Interim Condensed Consolidated Statements of Income
(in thousands of Canadian dollars, except per share amounts - unaudited)
Three months ended
Nine months ended
 
Note
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Revenues
18, 19
$752,052 $647,048 $2,241,417 $1,846,593 
Operating costs and expenses
Cost of revenues
538,435 463,362 1,606,658 1,331,691 
Selling, general and administrative114,187 107,283 359,811 321,304 
Restructuring costs
12
16,228 10,465 16,228 11,736 
Stock-based compensation
16
4,671 9,933 18,116 11,253 
Earnings from operations
 
78,531 56,005 240,604 170,609 
Net finance costs
20
17,537 19,733 49,945 43,900 
Income before income taxes
 
60,994 36,272 190,659 126,709 
Income tax expense
15
13,812 7,060 45,010 28,574 
Net income
 
$47,182 $29,212 $145,649 $98,135 
Attributable to
Shareholders
 
 
$47,048 $29,266 $145,276 $97,976 
Non-controlling interests
 
134 (54)373 159 
 
$47,182 $29,212 $145,649 $98,135 
Earnings per share attributable to shareholders



Basic
21
$0.48 $0.32 $1.49 $1.07 
Diluted
21
$0.47 $0.32 $1.48 $1.06 

See accompanying notes to the interim condensed consolidated financial statements.

2

ATS CORPORATION
Interim Condensed Consolidated Statements of Comprehensive Income
(in thousands of Canadian dollars - unaudited)
Three months ended
Nine months ended
 
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Net income
$47,182 $29,212 $145,649 $98,135 
Other comprehensive income (loss):
Items to be reclassified subsequently to net income:
Currency translation adjustment (net of income taxes of $nil)
(33)46,435 (15,061)17,910 
Net unrealized gain (loss) on derivative financial instruments designated as cash flow hedges
8,483 (2,167)9,624 (11,863)
Tax impact(2,155)491 (2,415)2,960 
Loss transferred to net income for derivatives designated as cash flow hedges
1,662 3,009 4,066 3,053 
Tax impact(422)(758)(1,021)(777)
Cross-currency interest rate swap adjustment(6,520)(4,510)(4,862)18,712 
Tax impact1,630 1,127 1,216 (4,678)
Variable for fixed interest rate swap adjustment(6,371)1,253 (2,573)1,253 
Tax impact1,593 (313)643 (313)
Other comprehensive income (loss)
(2,133)44,567 (10,383)26,257 
Comprehensive income
$45,049 $73,779 $135,266 $124,392 
Attributable to
Shareholders$44,881 $73,658 $135,125 $124,061 
Non-controlling interests168 121 141 331 
$45,049 $73,779 $135,266 $124,392 
    
See accompanying notes to the interim condensed consolidated financial statements.

3

ATS CORPORATION
Interim Condensed Consolidated Statements of Changes in Equity
(in thousands of Canadian dollars - unaudited)
Nine months ended December 31, 2023
 
 
Share capital
Contributed surplus
 
 Retained earnings
Currency translation adjustments 
 Cash flow hedge reserve
Total accumulated other comprehensive income
Non-controlling interestsTotal equity
Balance, as at March 31, 2023
$520,633 $15,468 $530,707 $51,206 $8,834 $60,040 $3,735 $1,130,583 
Net income
  145,276    373 145,649 
Other comprehensive income (loss)
   (14,829)4,678 (10,151)(232)(10,383)
Total comprehensive income (loss)
  145,276 (14,829)4,678 (10,151)141 135,266 
Non-controlling interest 4
  471    (666)(195)
Stock-based compensation
 8,146      8,146 
Exercise of stock options2,504 (550)     1,954 
U.S. initial public offering (note 14)
366,332       366,332 
Common shares held in trust (note 14)
(23,820)      (23,820)
 
Balance, as at December 31, 2023
$865,649 $23,064 $676,454 $36,377 $13,512 $49,889 $3,210 $1,618,266 
Nine months ended January 1, 2023
Share capitalContributed surplusRetained earningsCurrency translation adjustmentsCash flow hedge reserveTotal accumulated other comprehensive incomeNon-controlling interestsTotal equity
Balance, as at March 31, 2022
$530,241 $11,734 $416,773 $24,412 $(1,564)$22,848 $4,087 $985,683 
Net income
— — 97,976 — — — 159 98,135 
Other comprehensive income— — — 17,738 8,347 26,085 172 26,257 
Total comprehensive income— — 97,976 17,738 8,347 26,085 331 124,392 
Non-controlling interest — — 367 — — — (819)(452)
Stock-based compensation— 3,637 — — — — — 3,637 
Exercise of stock options2,460 (518)— — — — — 1,942 
Common shares held in trust(12,365)— — — — — — (12,365)
Repurchase of common shares
(3,561)— (17,510)— — — — (21,071)
 
Balance, as at January 1, 2023
$516,775 $14,853 $497,606 $42,150 $6,783 $48,933 $3,599 $1,081,766 

See accompanying notes to the interim condensed consolidated financial statements.
4

ATS CORPORATION
Interim Condensed Consolidated Statements of Cash Flows
(in thousands of Canadian dollars - unaudited)
Three months ended
Nine months ended
 
Note
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Operating activities
Net income
$47,182 $29,212 $145,649 $98,135 
Items not involving cash
Depreciation of property, plant and equipment
 
7,111 6,469 20,791 18,568 
Amortization of right-of-use assets
7
7,304 6,006 21,656 17,407 
Amortization of intangible assets
10
20,743 15,428 62,393 55,620 
Deferred income taxes
15
(8,693)1,033 (9,020)(13,192)
Other items not involving cash(1,871)(518)(2,433)8,029 
Stock-based compensation
16
3,043 1,508 8,146 3,637 
   Change in non-cash operating working capital35,689 57,011 (235,977)(141,809)
Cash flows provided by operating activities
$110,508 $116,149 $11,205 $46,395 
Investing activities
Acquisition of property, plant and equipment
 
$(12,045)$(18,588)$(46,516)$(32,723)
Acquisition of intangible assets
10
(5,666)(6,902)(15,971)(14,143)
Business acquisitions, net of cash acquired
4
(266,117)(18,163)(275,776)(18,163)
Settlement of cross-currency interest rate swap instrument8 —  21,493 
Proceeds from disposal of property, plant and equipment
 
14,554 525 22,809 1,431 
Cash flows used in investing activities
$(269,274)$(43,128)$(315,454)$(42,105)
Financing activities
Bank indebtedness $2,495 $(6,345)$(378)$9,549 
Repayment of long-term debt8(76,151)(181,897)(542,095)(196,199)
Proceeds from long-term debt310,844 325,270 626,828 395,559 
Proceeds from exercise of stock options775 338 1,954 1,942 
Proceeds from U.S. initial public offering,
    net of issuance fees
14 — 362,072 — 
Purchase of non-controlling interest
4
13 — (195)(452)
Repurchase of common shares —  (21,071)
Acquisition of shares held in trust16 (1,184)(23,820)(12,365)
Principal lease payments(5,135)(5,306)(18,250)(16,113)
Cash flows provided by financing activities
$232,841 $130,876 $406,116 $160,850 
Effect of exchange rate changes on cash and cash equivalents(569)3,085 (846)1,723 
Increase in cash and cash equivalents
73,506 206,982 101,021 166,863 
Cash and cash equivalents, beginning of period
187,382 95,163 159,867 135,282 
Cash and cash equivalents, end of period
$260,888 $302,145 $260,888 $302,145 
Supplemental information
Cash income taxes paid $7,946 $8,931 $33,662 $36,680 
Cash interest paid$20,814 $23,066 $54,952 $46,019 

See accompanying notes to the interim condensed consolidated financial statements.

5

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

1. CORPORATE INFORMATION

ATS Corporation and its subsidiaries (collectively, “ATS” or the “Company”) uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added solutions, including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers.

The Company is listed on the Toronto Stock Exchange and New York Stock Exchange under the ticker symbol “ATS” and is incorporated and domiciled in Ontario, Canada. The address of its registered office is 730 Fountain Street North, Cambridge, Ontario, Canada.

The interim condensed consolidated financial statements of the Company for the three and nine months ended December 31, 2023 were authorized for issue by the Board of Directors (the “Board”) on February 6, 2024.

2. BASIS OF PREPARATION

These interim condensed consolidated financial statements were prepared on a historical cost basis, except for derivative instruments that have been measured at fair value. The interim condensed consolidated financial statements are presented in Canadian dollars and all values are rounded to the nearest thousand, except where otherwise stated.

Statement of compliance
These interim condensed consolidated financial statements are prepared in accordance with International Accounting Standard (“IAS”) 34 - Interim Financial Reporting. Accordingly, certain information and disclosures normally included in annual financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”), as issued by the International Accounting Standards Board (“IASB”), have been omitted or condensed. These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements of the Company for the year ended March 31, 2023.

Standards adopted in fiscal 2024

The accounting policies adopted in the preparation of these interim condensed consolidated financial statements are consistent with those followed in the presentation of the Company's annual consolidated financial statements for the year ended March 31, 2023, except as noted below:

(i) Amendments to IAS 12 - Income taxes

Effective May 23, 2023, the IASB issued International Tax Reform - Pillar Two Model Rules (Amendments to IAS 12 - Income Taxes ("IAS 12")). The amendments provide a mandatory immediate temporary exception to accounting for deferred taxes arising from the Organization for Economic Co-operation and Development's (OECD) international tax reform and introduce additional disclosure requirements for annual financial statements. The Company has applied the mandatory temporary exception to recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes. The adoption did not have an impact on the Company's interim condensed consolidated financial statements.




6

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

3. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

The preparation of the Company’s interim condensed consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities at the end of the reporting period. However, uncertainty about these estimates, judgments and assumptions could result in outcomes that require a material adjustment to the carrying amount of the asset or liability affected in future periods.

The key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date, which have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next fiscal year, are consistent with those disclosed in the Company’s fiscal 2023 audited consolidated financial statements.

The Company based its estimates, judgments and assumptions on parameters available when the interim condensed consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising beyond the control of the Company. Such changes are reflected in the estimates when they occur.

7

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

4. ACQUISITIONS

(a) Current year acquisitions

(i) On November 16, 2023, the Company acquired 100% of the shares of Avidity Science, LLC ("Avidity"), a growing designer and manufacturer of automated water purification solutions for biomedical and life science applications. The total purchase price paid in the third quarter of fiscal 2024, pending post-closing adjustments was $271,948 ($198,611 U.S.).

Cash used in investing activities was determined as follows:
Cash consideration$271,948 
Less: cash acquired(6,100)
$265,848 
The preliminary allocation of the purchase price at fair value is as follows:
Purchase price allocation
Cash$6,100 
Other current assets44,877 
Property, plant and equipment10,370 
Right-of-use assets4,687 
Intangible assets with a definite life
Technology44,911 
Customer relationships60,932 
Other2,790 
Intangible assets with an indefinite life
Brands28,207 
Current liabilities(20,850)
Other long-term liabilities(5,346)
Deferred tax liability(33,264)
Net identifiable assets$143,414 
Residual purchase price allocated to goodwill128,534 
Purchase consideration$271,948 

Current assets include accounts receivable of $17,616, representing the fair value of accounts receivable expected to be collected.

The purchase cost was allocated to the underlying assets acquired and liabilities assumed based upon the estimated fair values at the date of acquisition. The fair value of the assets acquired and the liabilities assumed have been determined on a provisional basis based on information that is currently available to the Company. Final valuations of certain assets including working capital, property, plant and equipment and intangible assets are not yet complete due to timing of the acquisition and the inherent complexity associated with valuations. The allocation to intangible assets has preliminarily been determined using relative values from comparable transactions. Specifically, a third-party valuation has not been finalized. Therefore, the purchase price allocation is preliminary and is subject to adjustment upon completion of the valuation process and analysis of resulting tax effects.

8

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

The primary factors that contributed to a residual purchase price that resulted in the recognition of goodwill are: the acquired workforce, access to growth opportunities in new markets and with existing customers, and the combined strategic value to the Company’s growth plan. Of the amounts assigned to goodwill and intangible assets, approximately 17% of the aggregate are not expected to be deductible for tax purposes. This acquisition was accounted for as a business combination with the Company as the acquirer of Avidity. The purchase method of accounting was used with an acquisition date of November 16, 2023. Avidity contributed approximately $13,797 in revenue and $524 in net income from the acquisition date November 16, 2023 to December 31, 2023. If Avidity had been acquired at the beginning of ATS' fiscal year (April 1, 2023), the Company estimates that revenues and net income of the combined Avidity and ATS entity for the nine months ended December 31, 2023 would have been approximately $68,987 and $2,622 higher, respectively.

(ii) On July 3, 2023, the Company acquired 100% of the shares of Odyssey Validation Consultants Limited ("Odyssey"), an Ireland-based provider of digitalization solutions for the life sciences industry. The total purchase price was $5,636 (3,898 Euros), including $269 (187 Euros) paid in the third quarter of fiscal 2024.

On June 30, 2023, the Company acquired 100% of the shares of Yazzoom B.V. (“Yazzoom”), a Belgium-based provider of artificial intelligence and machine learning based tools for industrial production. The purchase price, paid in the first quarter of fiscal 2024, was $5,283 (3,655 Euros).

Cash used in investing activities for the two acquisitions was determined as follows:
Cash consideration$10,919 
Less: cash acquired(939)
$9,980 
The allocation of the purchase price at fair value for the two acquisitions is as follows:
Purchase price allocation
Cash$939 
Other current assets2,193 
Property, plant and equipment990 
Right-of-use assets423 
Intangible assets with a definite life
Technology2,856 
Brands1,318 
Customer relationships659 
Other1,429 
Current liabilities(3,895)
Other long-term liabilities(377)
Deferred tax liability(623)
Net identifiable assets$5,912 
Residual purchase price allocated to goodwill5,007 
Purchase consideration$10,919 

Current assets include accounts receivable of $1,351, representing the fair value of accounts receivable expected to be collected.

9

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

The purchase cost was allocated to the underlying assets acquired and liabilities assumed based upon the estimated fair values at the date of acquisition. The fair value of the assets acquired and the liabilities assumed have been finalized for Odyssey and Yazzoom. The allocations to intangible assets were determined using relative values from comparable transactions.

The primary factors that contributed to a residual purchase price that resulted in the recognition of goodwill are: the acquired workforce, access to growth opportunities in new markets and with existing customers, and the combined strategic value to the Company’s growth plan. The amounts assigned to goodwill and intangible assets are not expected to be deductible for tax purposes. These acquisitions were accounted for as business combinations with the Company as the acquirer of Yazzoom and Odyssey. The purchase method of accounting was used with an acquisition date of June 30, 2023 for Yazzoom, and July 3, 2023 for Odyssey.

(iii) On January 1, 2024, subsequent to the third quarter, the Company acquired IT.ACA. Engineering S.r.l. ("ITACA"), an Italian automation system integrator.

(b) Prior year acquisitions

(i) On March 28, 2023, the Company completed its acquisition of 100% of the membership interest in Triad Unlimited LLC (“Triad”), a U.S.-based reliability engineering service provider to the North American and European markets. The total purchase price paid upon finalization of working capital adjustments was $20,623 ($15,166 U.S.). Included in the purchase price was contingent consideration of $7,953 ($5,849 U.S.), which is payable if certain performance targets are met within two years of the acquisition date.

(ii) On March 3, 2023, the Company acquired 100% of the shares of Zi-Argus Australia Pty Ltd. and Zi-Argus Ltd. (“ZIA”). ZIA is an automation systems integrator serving Southeast Asia and Australia with a focus on process control, factory floor automation, data center and Industry 4.0 digitization solutions. The total purchase price paid in the fourth quarter of fiscal 2023, pending post-closing adjustments, was $24,500 ($18,015 U.S.).

The fair value of the assets acquired and the liabilities assumed have been determined on a provisional basis for ZIA and was finalized for Triad, based on information currently available to the Company. Final valuations of certain assets including intangible assets and working capital of ZIA are not yet complete due to the inherent complexity associated with valuations. As well, the purchase price of the ZIA acquisition is subject to post-closing adjustments. During the nine months ended December 31, 2023, changes to the purchase price allocation for the two acquisitions resulted in increases to purchase price of $283, cash of $336, intangible assets of $559, long-term debt of $421, the deferred tax liability of $92, decreases in working capital of $936, property, plant and equipment of $98, other long-term liabilities of $171 and an increase to goodwill of $764.

5. INVENTORIES
As at
December 31
2023
March 31
2023
Raw materials$152,934 $138,792 
Work in progress113,161 84,401 
Finished goods46,667 33,673 
$312,762 $256,866 

The amount charged to net income and included in cost of revenues for the write-down of inventories for valuation issues during the three and nine months ended December 31, 2023 was $1,399 and
10

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

$4,429 respectively (three and nine months ended January 1, 2023 - $181 and $1,179, respectively). The amount of inventories carried at net realizable value as at December 31, 2023 was $5,421 (March 31, 2023 - $591).

6. DEPOSITS, PREPAIDS AND OTHER ASSETS    

As at
December 31
2023
March 31
2023
Prepaid assets$35,826 $29,766 
Supplier deposits41,867 45,565 
Investment tax credit receivable21,671 13,819 
Forward foreign exchange contracts13,823 4,200 
$113,187 $93,350 

7. RIGHT-OF-USE ASSETS AND LEASE LIABILITIES

Changes in the net balance of right-of-use assets during the nine months ended December 31, 2023 were as follows:
NoteBuildings
Vehicles and equipment
Total
Balance, at March 31, 2023
$79,880 $14,332 $94,212 
Additions19,940 8,340 28,280 
Amortization(15,858)(5,798)(21,656)
Acquisition of subsidiaries
4
4,003 1,109 5,112 
Exchange and other adjustments378 52 430 
Balance, at December 31, 2023
$88,343 $18,035 $106,378 

Changes in the balance of lease liabilities during the nine months ended December 31, 2023 were as follows:
Note
 
Balance, at March 31, 2023
$97,249 
Additions28,280 
Interest4,031 
Payments(22,281)
Acquisition of subsidiaries
4
6,105 
Exchange and other adjustments(1,460)
Balance, at December 31, 2023
$111,924 
Less: current portion26,661 
$85,263 

The right-of-use assets and lease liabilities relate to leases of real estate properties, automobiles and other equipment. For the three and nine months ended December 31, 2023, the Company recognized expense related to short-term and low-value leases of $1,467 and $3,693, respectively, in cost of revenues (January 1, 2023 - $621 and $1,757, respectively), and $420 and $929, respectively, in selling, general and administrative expenses (January 1, 2023 - $848 and $1,904, respectively) in the interim condensed consolidated statements of income.

11

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

8. OTHER ASSETS AND LIABILITIES

Other assets consist of the following:
As at
December 31
2023
March 31
2023
Cross-currency interest rate swap instrument (i)
$11,325 $16,187 
Variable for fixed interest rate swap instrument (ii)
 467 
Other          
14 25 
Total          
$11,339 $16,679 
Other liabilities consist of the following:
As at
December 31
2023
March 31
2023
Cross-currency interest rate swap instrument (i)
$14,593 $10,718 
Variable for fixed interest rate swap instrument (ii)
2,106 — 
Total          
$16,699 $10,718 

(i) On April 20, 2022, the Company entered into a cross-currency interest rate swap instrument to swap U.S. $175,000 into Canadian dollars to hedge a portion of its foreign exchange risk related to its U.S. dollar-denominated Senior Notes. The Company will receive interest of 4.125% U.S. per annum and pay interest of 4.169% Canadian. The terms of the hedging instrument will end on December 15, 2025.

The Company entered into a cross-currency interest rate swap instrument on April 20, 2022 to swap 161,142 Euros into Canadian dollars to hedge the net investment in European operations. The Company will receive interest of 4.169% Canadian per annum and pay interest of 2.351% Euros. The terms of the hedging relationship will end on December 15, 2025.

(ii) Effective November 4, 2022, the Company entered into a variable for fixed interest rate swap instrument to swap the variable interest rate on its $300,000 non-amortized secured term credit facility to a fixed 4.241% interest plus a margin. The terms of the hedging instrument will end on November 4, 2024.

On November 21, 2023, the Company entered into a variable for fixed interest rate swap instrument to swap the variable interest rate on its $300,000 non-amortized secured term credit facility to a fixed 4.044% interest plus a margin for the period November 4, 2024 to November 4, 2026.

9. GOODWILL

The carrying amount of goodwill acquired through business combinations has been allocated to a group of CGUs that combine to form a single operating segment, ATS Corporation, as follows:
                
As at
Note          
December 31
2023
March 31
2023
Balance, at April 1$1,118,262 $1,024,790 
Acquisition of subsidiaries
4
134,305 23,758 
Foreign exchange(14,683)69,714 
Balance, at December 31, 2023
$1,237,884 $1,118,262 



12

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

10. INTANGIBLE ASSETS
NoteDevelopment projectsComputer software, licenses and otherTechnologyCustomer relationships
Brands(i)
Total
Cost:
Balance, at March 31, 2023
$68,222 $55,689 $278,510 $348,733 $171,035 $922,189 
Additions11,251 4,720 — — — 15,971 
Acquisition of subsidiaries     
4
1,170 3,145 48,040 61,653 29,652 143,660 
Disposals(620)(664)— — — (1,284)
Exchange and other adjustments(6,607)3,302 (15,517)(65,974)(2,799)(87,595)
Balance, at December 31, 2023
$73,416 $66,192 $311,033 $344,412 $197,888 $992,941 
 
 
Development projectsComputer software, licenses and otherTechnologyCustomer relationships
Brands(i)
Total
Amortization:
Balance, at March 31, 2023
$(27,755)$(34,878)$(79,670)$(183,729)$(2,947)$(328,979)
Amortization(4,825)(10,049)(22,974)(21,705)(2,840)(62,393)
Disposals— 658 — — — 658 
Exchange and other adjustments74 6,532 11,983 61,489 11 80,089 
Balance, at December 31, 2023
$(32,506)$(37,737)$(90,661)$(143,945)$(5,776)$(310,625)
 
Net book value:
At December 31, 2023
$40,910 $28,455 $220,372 $200,467 $192,112 $682,316 
At March 31, 2023
$40,467 $20,811 $198,840 $165,004 $168,088 $593,210 

(i) The Company has assessed a portion of its brand intangible assets to have a useful life of 5 years. The carrying amount of the intangible assets estimated to have an indefinite life as at December 31, 2023 was $182,266 (March 31, 2023 - $156,732).

11. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

During the three and nine months ended December 31, 2023 and the three and nine months ended January 1, 2023, there were no changes in the classification of financial assets as a result of a change in the purpose or use of those assets.

During the three and nine months ended December 31, 2023 and the three and nine months ended January 1, 2023, there were no transfers of financial instruments between Level 1 and Level 2 fair value measurements, and no transfers into or out of Level 3 fair value measurements.

Instruments not subject to hedge accounting
As part of the Company’s risk management strategy, forward contract derivative financial instruments are used to manage foreign currency exposure related to the translation of foreign currency net assets to the subsidiary’s functional currency. As these instruments have not been designated as hedges, the change in fair value is recorded in selling, general and administrative expenses in the interim condensed consolidated statements of income.

For the three and nine months ended December 31, 2023, the Company recorded risk management gains of $1,487 and $6,333, respectively (three and nine months ended January 1, 2023 - losses of $17,875 and $20,739, respectively), on foreign currency risk management forward contracts in the
13

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

interim condensed consolidated statements of income. Included in these amounts, during the three and nine months ended December 31, 2023, were unrealized gains of $2,222 and $2,546, respectively (three and nine months ended January 1, 2023 - unrealized gains of $166 and losses of $3,783, respectively), representing the change in fair value. In addition, during the three and nine months ended December 31, 2023, the Company realized foreign exchange losses of $735 and gains of $3,787, respectively (three and nine months ended January 1, 2023 - losses of $18,041 and $16,956, respectively), which were settled.

12. PROVISIONS

WarrantyRestructuringOtherTotal
Balance, at March 31, 2023
$11,102 $18,590 $908 $30,600 
Provisions made5,183 16,228 6,455 27,866 
Acquisition of subsidiaries526 — — 526 
Provisions used(3,665)(11,974)(6,535)(22,174)
Exchange adjustments(108)(80)(7)(195)
Balance, at December 31, 2023
$13,038 $22,764 $821 $36,623 
            
Warranty provisions
Warranty provisions are related to sales of products and are based on experience reflecting statistical trends of warranty costs.

Restructuring
Restructuring charges are recognized in the period incurred and when the criteria for provisions are fulfilled. Termination benefits are recognized as a liability and an expense when the Company is demonstrably committed through a formal restructuring plan.

The Company periodically undertakes reviews of its operations to ensure alignment with strategic market opportunities. As part of this review, the Company has identified an opportunity to improve the cost structure of the organization and reallocate investment to growth areas. In the third quarter of fiscal 2024, restructuring expenses of $16,228 were recorded in relation to the reorganization. The majority of the remaining actions are expected to be completed during the fourth quarter of fiscal 2024. The total estimated cost of these activities is expected to be at the higher end of the previously disclosed range of $15,000 to $20,000.

In fiscal 2023, the Company completed a reorganization plan which primarily impacted certain management positions.

Other provisions
Other provisions are related to medical insurance expenses that have been incurred during the period but are not yet paid, and other miscellaneous provisions.

13. BANK INDEBTEDNESS AND LONG-TERM DEBT

On October 5, 2023, the Company amended its senior secured credit facility (the “Credit Facility”) to extend the term loan maturity to match the maturity of the revolving line of credit. The Credit Facility consists of (i) a $750,000 secured committed revolving line of credit and (ii) a fully drawn $300,000 non-amortized secured term credit facility; both maturing on November 4, 2026. The Credit Facility is secured by the Company’s assets, including a pledge of shares of certain of the Company’s subsidiaries. Certain of the Company’s subsidiaries also provide guarantees under the Credit Facility. At
14

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

December 31, 2023, the Company had utilized $763,021 under the Credit Facility, of which $763,009 was classified as long-term debt (March 31, 2023 - $691,906) and $12 by way of letters of credit (March 31, 2023 - $48). During the nine months ended December 31, 2023, the Company drew $580,823 and repaid $541,973 on its Credit Facility, which included proceeds from the public offering of the Company's common shares on the New York Stock Exchange.
The Credit Facility is available in Canadian dollars by way of prime rate advances and/or bankers’ acceptances, in U.S. dollars by way of base rate advances and/or Term SOFR, in Euros by way of EURIBOR advances, in British pounds sterling by way of Daily Simple SONIA advances, and by way of letters of credit for certain purposes. The interest rates applicable to the Credit Facility are determined based on a net debt-to-EBITDA ratio as defined in the Credit Facility. For prime rate advances and base rate advances, the interest rate is equal to the bank’s prime rate or the bank’s U.S. dollar base rate in Canada, respectively, plus a margin ranging from 0.45% to 2.00%. For bankers’ acceptances, Term SOFR, EURIBOR advances and Daily Simple SONIA advances, the interest rate is equal to the bankers’ acceptance fee, Term SOFR rate, EURIBOR rate or Daily Simple SONIA rate, respectively, plus a margin that varies from 1.45% to 3.00%. The Company pays a fee for usage of financial letters of credit that ranges from 1.45% to 3.00%, and a fee for usage of non-financial letters of credit that ranges from 0.97% to 2.00%. The Company pays a standby fee on the unadvanced portions of the amounts available for advance or drawdown under the Credit Facility at rates ranging from 0.29% to 0.60%. The Company's Credit Facility is subject to changes in market interest rates. Changes in economic conditions outside of the Company's control could result in higher interest rates, thereby increasing its interest expense. The Company uses a variable for fixed interest rate swap to hedge a portion of its Credit Facility (see note 8).

The Credit Facility is subject to financial covenants including a net debt-to-EBITDA test and an interest coverage test. Under the terms of the Credit Facility, the Company is restricted from encumbering any assets with certain permitted exceptions. At December 31, 2023, all of the covenants were met.

The Company has additional credit facilities available of $104,157 (40,776 Euros, $24,000 U.S., 45,000 Thai Baht, 5,000 GBP, 5,000 CNY, $150 AUD and $1,462 CAD). The total amount outstanding on these facilities as at December 31, 2023 was $7,611, of which $5,179 was classified as bank indebtedness (March 31, 2023 - $5,824), $1,838 was classified as long-term debt (March 31, 2023 - $202) and $594 by way of letters of credit (March 31, 2023 - $158). The interest rates applicable to the credit facilities range from 0.03% to 8.45% per annum. A portion of the long-term debt is secured by certain assets of the Company.

The Company’s U.S. $350,000 aggregate principal amount of senior notes (“the Senior Notes”) were issued at par, bear interest at a rate of 4.125% per annum and mature on December 15, 2028. After December 15, 2023, the Company may redeem the Senior Notes, in whole at any time or in part from time to time, at specified redemption prices and subject to certain conditions required by the Senior Notes. If the Company experiences a change of control, the Company may be required to repurchase the Senior Notes, in whole or in part, at a purchase price equal to 101% of the aggregate principal amount of the Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The Senior Notes contain customary covenants that restrict, subject to certain exceptions and thresholds, some of the activities of the Company and its subsidiaries, including the Company’s ability to dispose of assets, incur additional debt, pay dividends, create liens, make investments, and engage in specified transactions with affiliates. At December 31, 2023, all of the covenants were met. Subject to certain exceptions, the Senior Notes are guaranteed by each of the subsidiaries of the Company that is a borrower or has guaranteed obligations under the Credit Facility. Transaction fees of $8,100 were deferred and are being amortized over the term of the Senior Notes.
15

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

The Company uses a cross-currency interest rate swap instrument to hedge a portion of its U.S.-dollar-denominated Senior Notes (see note 8).

(i) Bank indebtedness
As at
December 31
2023
March 31
2023
Other facilities$5,179 $5,824 

(ii) Long-term debt

As at
December 31
2023
March 31
2023
Credit Facility$763,009 $691,906 
Senior Notes463,750 472,990 
Other facilities1,838 202 
Issuance costs(8,785)(9,312)
1,219,812 1,155,786 
Less: current portion207 65 
$1,219,605 $1,155,721 

Scheduled principal repayments and interest payments on long-term debt as at December 31, 2023 are as follows (variable interest repayments on the Credit Facility are not reflected in the table below as they fluctuate based on the amounts drawn):




Principal

Interest
Less than one year$207 $19,250 
One - two years287 19,242 
Two - three years670,420 19,234 
Three - four years92,860 19,225 
Four - five years463,869 19,216 
Thereafter954 262 
$1,228,597 $96,429 
        
14. SHARE CAPITAL

Authorized share capital of the Company consists of an unlimited number of common shares, without par value, for unlimited consideration.

On May 30, 2023, the Company announced the closing of its U.S. initial public offering on the New York Stock Exchange. A total of 6,900,000 common shares were sold by the Company, at a price of $55.04 ($41 U.S.) per share, for gross proceeds to the Company of $379,797 ($282,900 U.S.). Offering costs of $17,725 ($13,203 U.S.) were paid and deferred tax of $4,260 ($3,173 U.S.) related to the offering costs were recorded to share capital.

On December 13, 2023, the Company announced that the Toronto Stock Exchange (“TSX”) had accepted a notice filed by the Company of its intention to make a normal course issuer bid (“NCIB”). Under the NCIB, ATS may purchase for cancellation up to a maximum of 8,044,818 common shares during the 12-month period ending December 14, 2024.

16

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

For the nine months ended December 31, 2023, the Company purchased nil common shares under the recently announced and previous NCIB programs. All purchases are made in accordance with the bid at prevalent market prices plus brokerage fees, or such other prices that may be permitted by the TSX, with consideration allocated to share capital up to the average carrying amount of the shares, and any excess allocated to retained earnings.

The changes in the common shares issued and outstanding during the period presented were as follows:
Number of common sharesShare capital
Balance, at March 31, 2023
91,602,192 $520,633 
Exercise of stock options89,773 2,504 
Initial public offering, net of offering costs and deferred tax6,900,000 366,332 
Common shares held in trust(387,794)(23,820)
Balance, at December 31, 2023
98,204,171 $865,649 

15. TAXATION

(i) Reconciliation of income taxes: Income tax expense differs from the amounts that would be obtained by applying the combined Canadian basic federal and provincial income tax rate to income before income taxes. These differences result from the following items:

17

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

Three months ended
Nine months ended
 
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Income before income taxes and non-controlling interest
$60,994 $36,272 $190,659 $126,709 
Combined Canadian basic federal and provincial income tax rate26.50%26.50%26.50%26.50%
Income tax expense based on combined Canadian basic
    federal and provincial income tax rate
$16,164 $9,612 $50,525 $33,578 
Increase (decrease) in income taxes resulting from:
Adjustments in respect of current income tax of previous periods(93)2,620 659 2,656 
Non-taxable items net of non-deductible items
(1,875)(4,227)(5,549)(4,476)
Unrecognized assets2,829 1,657 7,436 5,094 
Income taxed at different rates and statutory rate changes(2,469)(2,351)(6,548)(7,078)
Manufacturing and processing allowance and all other items(744)(251)(1,513)(1,200)
At the effective income tax rate of 24%
(January 1, 2023 – 23%)
$13,812 $7,060 $45,010 $28,574 
Income tax expense reported in the interim condensed consolidated statements of income:
Current tax expense
$22,505 $6,027 $54,030 $41,766 
Deferred tax expense (recovery)
(8,693)1,033 (9,020)(13,192)
$13,812 $7,060 $45,010 $28,574 
Deferred tax related to items charged or
credited directly to equity and goodwill:
Gain (loss) on revaluation of cash flow hedges
$686 $547 $(1,537)$(2,808)
Opening deferred tax of acquired company
4
(33,264)(3,718)(33,979)(3,718)
Other items recognized through equity1,138 (419)5,936 (6,119)
Income tax charged directly to equity and goodwill$(31,440)$(3,590)$(29,580)$(12,645)

16. STOCK-BASED COMPENSATION

In the calculation of the stock-based compensation expense in the interim condensed consolidated statements of income, the fair value of the Company’s stock option grants were estimated using the Black-Scholes option pricing model for time-vesting stock. During the three and nine months ended December 31, 2023, the Company granted nil and 176,112 time vesting stock options (nil and 223,144 in the three and nine months ended January 1, 2023, respectively). The stock options granted vest over four years and expire on the seventh anniversary from the date of issue.










18

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

 For the nine months ended
December 31
2023
January 1
2023
Number of stock optionsWeighted average exercise priceNumber of stock optionsWeighted average exercise price
Stock options outstanding, beginning of year785,429 $26.69 890,408 $21.04 
Granted176,112 57.71223,144 36.42
Exercised (i)
(89,773)21.78(122,845)15.81
Forfeited(6,382)37.87(25,665)24.86
Stock options outstanding, end of year865,386 $33.43 965,042 $25.16 
Stock options exercisable, end of year, time-vested options385,108 $24.06 455,238 $19.95 

(i) For the nine months ended December 31, 2023, the weighted average share price at the date of exercise was $58.20 (January 1, 2023 - $40.69).

The fair values of the Company’s stock options issued during the periods presented were estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions. Expected stock price volatility was determined at the time of the grant by considering historical share price volatility. Expected stock option grant life was determined at the time of the grant by considering the average of the grant vesting period and the grant exercise period.

 For the nine months ended
December 31
2023
January 1
2023
Weighted average risk-free interest rate3.52 %2.66 %
Dividend yield0 %%
Weighted average expected volatility36 %34 %
Weighted average expected life4.77 years4.75 years
Number of stock options granted:
Time-vested
176,112223,144
Weighted average exercise price per option$ 57.71$ 36.42
Weighted average value per option:
Time-vested
$ 20.83$ 12.24
Restricted Share Unit Plan:

During the three and nine months ended December 31, 2023, the Company granted 9,740 and 161,568 time-vesting restricted share units (“RSUs”) (4,921 and 203,300 in the three and nine months ended January 1, 2023), nil and 126,944 performance-based RSUs (nil and 152,690 in the three and nine months ended January 1, 2023). The Company measures these RSUs based on the fair value at the date of grant and a compensation expense is recognized over the vesting period in the interim condensed consolidated statements of income with a corresponding increase in contributed surplus. The performance-based RSUs vest upon successful achievement of certain operational and share price targets.

On May 18, 2022, the RSU plan was amended so that RSUs granted may be settled in ATS Common Shares, where deemed advisable by the Company, as an alternative to cash payments. It is the Company's intention to settle these RSUs with ATS Common Shares and therefore the Company measures these RSUs as equity awards based on fair value. At December 31, 2023, 725,290 shares are held in a trust and may be used to settle some or all of the RSU grants when they are fully vested. The trust is consolidated in the Company's interim condensed consolidated financial statements with the value of the acquired common shares presented as a reduction of share capital.

19

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

The RSUs issued prior to May 18, 2022 give the employee the right to receive a cash payment based on the market value of a common share of the Company. The RSU liability is recognized quarterly based on the expired portion of the vesting period and the change in the Company’s stock price. The change in value of the RSU liability is included in the interim condensed consolidated statements of income in the period of the change. At December 31, 2023, the value of the outstanding liability related to the RSU plan was $17,129 (March 31, 2023 - $36,177). The RSU liability is included in accounts payable and accrued liabilities on the interim condensed consolidated statements of financial position.

The weighted average remaining vesting period for the time-vesting RSUs and performance-based RSUs to be settled in cash is 0.5 years.

Deferred Stock Unit Plan:

During the three and nine months ended December 31, 2023, the Company granted 3,103 and 32,498 units, respectively (three and nine months ended January 1, 2023 - nil and 33,998, respectively). The Deferred Stock Unit ("DSU") liability is revalued at each reporting date based on the change in the Company’s stock price. The change in value of the DSU liability is included in the interim condensed consolidated statements of income. As at December 31, 2023, the value of the outstanding liability related to the DSUs was $24,156 (March 31, 2023 - $22,565). The DSU liability is revalued at each reporting date based on the change in the Company’s stock price. The DSU liability is included in accounts payable and accrued liabilities on the interim condensed consolidated statements of financial position. The change in the value of the DSU liability is included in the interim condensed consolidated statements of income in the period of change.

The following table shows the compensation expense related to the Company's share-based payment plans:

For the three months ended
December 31
2023
January 1
2023
Stock options$492 $ 470
RSUs4,027 6,957 
DSUs152 2,506 
$4,671 $9,933 

For the nine months ended
December 31
2023
January 1
2023
Stock options$1,504 $1,318 
RSUs15,021 9,960 
DSUs1,591 (25)
$18,116 $11,253 

17. COMMITMENTS AND CONTINGENCIES

The minimum purchase obligations are as follows as at December 31, 2023:
Less than one year$424,394 
One - two years9,183 
Two - three years1,407 
Three - four years470 
Four - five years24 
$435,478 
20

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

The Company’s off-balance sheet arrangements consist of purchase obligations, primarily commitments for material purchases, which have been entered into in the normal course of business.

In accordance with industry practice, the Company is liable to customers for obligations relating to contract completion and timely delivery. In the normal conduct of its operations, the Company may provide letters of credit as security for advances received from customers pending delivery and contract performance. In addition, the Company provides letters of credit for post-retirement obligations and may provide letters of credit as security on equipment under lease and on order. As at December 31, 2023, the total value of outstanding letters of credit was approximately $176,730 (March 31, 2023 - $192,508).

In the normal course of operations, the Company is party to a number of lawsuits, claims and contingencies. Although it is possible that liabilities may be incurred in instances for which no accruals have been made, the Company does not believe that the ultimate outcome of these matters will have a material impact on its interim condensed consolidated statements of financial position.

18. SEGMENTED DISCLOSURE

The Company’s operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements best practices on a global basis.

Geographic segmentation of revenues is determined based on revenues by customer location. Non-current assets represent property, plant and equipment, right-of-use assets and intangible assets that are attributable to individual geographic segments, based on location of the respective operations.

As at
December 31, 2023
Right-of-use assetsProperty, plant and equipmentIntangible assets
Canada$31,545 $63,069 $27,824 
United States11,860 131,728 440,072 
Germany24,820 35,544 37,041 
Italy18,061 39,636 134,270 
Other Europe14,835 12,196 33,414 
Other5,257 2,283 9,695 
Total Company$106,378 $284,456 $682,316 
As at
March 31, 2023
Right-of-use assetsProperty, plant and equipmentIntangible
assets
Canada$21,384 $57,589 $25,584 
United States12,514 111,702 334,731 
Germany25,250 35,848 43,291 
Italy21,136 40,645 145,217 
Other Europe9,031 16,049 33,729 
Other4,897 1,286 10,658 
Total Company$94,212 $263,119 $593,210 

21

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

Revenue from external customers
Three months ended
Nine months ended
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Canada$27,653 $24,149 $92,580 $77,470 
United States365,930 327,688 1,089,685 954,214 
Germany72,824 65,187 219,118 180,691 
Italy25,481 16,902 91,953 60,678 
Other Europe135,405 124,247 431,887 332,486 
Other124,759 88,875 316,194 241,054 
Total Company$752,052 $647,048 $2,241,417 $1,846,593 

For the nine months ended December 31, 2023, the Company had revenues from a single customer that amounted to 25.8% of total consolidated revenues. For the nine months ended January 1, 2023, the Company had revenues from a single customer that amounted to 14.0% of total consolidated revenues.

19. REVENUE FROM CONTRACTS WITH CUSTOMERS

(a) Revenue by type:

Three months ended
Nine months ended
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Revenues from construction contracts$485,202 $422,171 $1,473,825 $1,159,668 
Services rendered153,016 124,255 444,397 354,884 
Sale of goods113,834 100,622 323,195 332,041 
Total Company$752,052 $647,048 $2,241,417 $1,846,593 

(b) Disaggregation of revenue from contracts with customers:

Three months ended
Nine months ended
Revenues by market
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Life Sciences$316,873 $304,138 $893,301 $885,402 
Transportation240,442 161,555 711,176 379,108 
Food & Beverage94,885 88,468 335,339 272,241 
Consumer Products68,976 69,951 217,160 222,935 
Energy30,876 22,936 84,441 86,907 
Total Company$752,052 $647,048 $2,241,417 $1,846,593 

Three months ended
Nine months ended
Timing of revenue recognition based on transfer of control
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Goods and services transferred at a point in time$113,834 $100,622 $323,195 $332,041 
Goods and services transferred over time638,218 546,426 1,918,222 1,514,552 
Total Company$752,052 $647,048 $2,241,417 $1,846,593 





22

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

(c) Contract balances:
As at
December 31
2023
March 31
2023
Trade receivables$522,414 $368,855 
Contract assets589,693 526,990 
Contract liabilities(356,311)(296,555)
Unearned revenue (i)
(43,019)(33,490)
Net contract balances$712,777 $565,800 
(i) The unearned revenue liability is included in accounts payable and accrued liabilities on the interim condensed consolidated statements of financial position.

As at
December 31
2023
March 31
2023
Contracts in progress:
Costs incurred$3,678,016 $3,285,121 
Estimated earnings1,260,760 1,091,180 
4,938,776 4,376,301 
Progress billings(4,705,394)(4,145,866)
Net contract assets and liabilities$233,382 $230,435 

20. NET FINANCE COSTS
Three months ended
Nine months ended
Note
December 31
2023
January 1
2023
December 31
2023
January 1
2023
Interest expense$16,898 $19,610 $47,516 $42,071 
Interest on lease liabilities71,387 920 4,031 2,840 
Interest income(748)(797)(1,602)(1,011)
$17,537 $19,733 $49,945 $43,900 

21. EARNINGS PER SHARE    

Basic earnings per share
Earnings per common share is calculated by dividing earnings attributable to common shareholders by the weighted average number of common shares outstanding.

Diluted earnings per share
The treasury stock method is used to determine the dilutive impact of stock options and RSUs. This method assumes any proceeds from the exercise of stock options and vesting of RSUs would be used to purchase common shares at the average market price during the period.

For the three months ended
December 31
2023
January 1
2023
Weighted average number of common shares outstanding98,906,456 91,761,204 
Dilutive effect of RSUs130,049 59,249 
Dilutive effect of performance-based RSUs190,446 — 
Dilutive effect of stock option conversion313,096 365,579 
Diluted weighted average number of common shares outstanding99,540,047 92,186,032 

23

ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
    (in thousands of Canadian dollars, except per share amounts - unaudited)    

For the nine months ended
December 31
2023
January 1
2023
Weighted average number of common shares outstanding97,373,957 91,836,696 
Dilutive effect of RSUs128,582 26,060 
Dilutive effect of performance-based RSUs256,945 — 
Dilutive effect of stock option conversion357,400 340,539 
Diluted weighted average number of common shares outstanding98,116,884 92,203,295 

For the three and nine months ended December 31, 2023, stock options to purchase 188,684 and 174,372 common shares, respectively and RSUs of 146,091 and 125,690, respectively are excluded from the weighted average number of common shares in the calculation of diluted earnings per share as they are anti-dilutive (220,602 common shares and nil RSUs were excluded for the three and nine months ended January 1, 2023).

24